Patent & IP news for October 16, 2009

Patent Litigations

  • No new litigations this day!



Patent & IP Blogs

post image SpicyIP Teasip: Darjeeling Tea almost a G.I. in the E.U. from

After a wait for almost two years, Darjeeling Tea, is now on the verge of being granted the status of a Geographical Indication by the European Union. The EU is currently inviting public comments. This ...

Share via E–mail | Twitter | Facebook

post image Those IP security interests again: calling all stakeholders! from

Following what was an extremely interesting and constructive seminar earlier this week on the UNCITRAL proposals for dealing with securitised interests in IP rights, the Intellectual Property Office (that's the operating name of the ...

Share via E–mail | Twitter | Facebook

post image Wrestlers get to grips with winos -- but will they get a SmackDown? from

The IPKat thanks his old friend Miri Frankel (Beanstalk) for drawing his attention to an instance of a litigious trade mark owner intent quite literally on getting to grips with its adversary. The litigant in ...

Share via E–mail | Twitter | Facebook

post image Friday flappings from

It's Friday again, time to check the IPKat's sidebar for all those forthcoming events. There's a huge selection, as ever. See you there?

Around the blogs.
The 1709 Blog, which launched in ...

Share via E–mail | Twitter | Facebook

post image Patent Litigation Weekly: Foley Tries Turning Tables on Spangenberg from

This week, the man behind a notorious network of patent-holding companies finds himself in an unaccustomed spot: on the defense. When it comes to litigation, Erich Spangenberg, well known for runing a network of litigious ...

Share via E–mail | Twitter | Facebook

Pooling patents for HIV drugs: A paradigm shift from

Nirav Bhatt is an LLM candidate at Osgoode Hall Law School. According to a report, AIDS, which is caused due to Human immunodeficiency virus (HIV) killed more than 25 million people worldwide from 1981 to ...

Share via E–mail | Twitter | Facebook

Ranbaxy wins against Roche in DNJ on valganciclovir from

Daiichi-Ranbaxy prevailed against Roche Palo Alto (formerly Syntex) in the District Court of New Jersey by securing a finding of noninfringement of the claims of US 6,083,953 directed to crystalline valganciclovir. Roche had ...

Share via E–mail | Twitter | Facebook

An Ethical Framework For IP And Climate Change from

BANGKOK - Normal negotiation strategy is unlikely to result in an impact on climate change, since the most important stakeholders in fighting it - not yet born - have no seat at the negotiating tables, said a panel ...

Share via E–mail | Twitter | Facebook

Anti-Innovation Chorus Continues Over Biologics from

A press release issued earlier today by the Pharmaceutical Care Management Association (PCMA) explained that a new article published in the New England Journal of Medicine (NEJM) urges Congress and the White House to revisit ...

Share via E–mail | Twitter | Facebook

Patent Reform: Reverse Payments from

Most patent infringement lawsuits are resolved with an agreement for the accused infringer to pay money to the patent right-holder. Generic drug-maker challenges to pharmaceutical patents occasionally follow a different path – with the patent holder ...

Share via E–mail | Twitter | Facebook

Kappos to Speak at ACCA Meeting in Boston from

The Association of Corporate Counsel (ACC) announced this week that it will feature USPTO Director David Kappos at its 2009 Annual Meeting in Boston next week. Kappos will appear on an interactive panel discussion, “Meet ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact